Therapeutic Apheresis - A US Market Review : Market Research Report

Therapeutic Apheresis - A US Market Review

Published: Nov. 1, 2009 - 48 Pages

1. METHODOLOGY: Study Reliability and Reporting Limitations; Disclaimers; Quantitative Techniques & Reporting Level
2. MARKET ANALYSIS: A Promising Outlook
3. MARKET TRENDS: Apheresis Process Leads to Rise in Platelet Donors; Therapeutic Apheresis Devices - A Perplexing Market; Plateletpheresis: The Treatment of Choice for Patients; Photopheresis Market Growing at a High Rate; Vendors’ Attitude Hampers Growth Prospects of Therapeutic Apheresis; Developing New Applications for Therapeutic Apheresis is the Need of the Hour; CFA - An Effective Way to Pull Up Cold Hemagglutinin Disease
4. COMPETITIVE SCENARIO: Overview; Technology: The Only Key for Success; CaridianBCT: The World Leader; Market Share Trends in the Recent Past
5. MARKET OVERVIEW & OUTLOOK: Market Drivers; Market Restraints; Market Challenges; Pediatry: An Untapped Opportunity
6. REGULATORY ENVIRONMENT
7. PRODUCT FACTS: Plasmapheresis; Immunoadsorption; Erythrocytapheresis; Plateletpheresis; Leukapheresis; Photopheresis; Lipidpheresis
8. PRODUCT TRENDS AND ISSUES: Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP) Replacement; Risks Associated with Therapeutic Apheresis; Categories of Indications for Therapeutic Apheresis; Plasma Exchange and Plasmapheresis: The Difference; Applications of Plasma Exchange; Emerging Applications
9. CORPORATE DEVELOPMENTS: Gambro to Change Name to CaridianBCT; Therakos Obtains CE Mark in Europe; Baxter Divests Transfusion Therapies Business; SCSG Gets Hold of Fresenius Medical Care Extracorporeal Alliance; Rheologics Technologies Takes Over Cardiodyne Electronics; Biotest Obtains Business Unit of Nabi BioPharmaceuticals; Gambro BCT Receives FDA Clearance for Spectra Optia System; MedaSorb Receives Rights for Blood Processing
10. MAJOR PLAYERS: Baxter Healthcare Corporation; CaridianBCT, Inc.; Fenwal, Inc.; Fresenius Medical Care North America (FMCNA); Haemonetics Corporation; HemaCare Corporation; Hospital Clinical Services Group, Inc. (HCSG); Therakos, Inc
11. MARKET ANALYTICS
EXHIBITS: Table 1: Percentage Breakdown of Leading Players in the US Market for Therapeutic Apheresis - 2005; Table 2: Percentage Breakdown of Leading Players in the US Market for Therapeutic Apheresis - 2005; Table 3: Percentage Breakdown of Leading Players in the US Market for Therapeutic Apheresis in Neurological Disorders - 2005; Table 4: Percentage Breakdown of Leading Players in the US Market for Therapeutic Apheresis in Neurological Disorders - 2005; Table 5: Percentage Breakdown of Leading Players in the US Market for Therapeutic Apheresis in Hematology and Oncology Disorders - 2005; Table 6: Percentage Breakdown of Leading Players in the US Market for Therapeutic Apheresis in Hematology and Oncology Disorders - 2005; Table 7: Therapeutic Apheresis Market by Procedure in the US: 2007-2015 (Sales in US$ Thousand); Table 8: Percentage Breakdown of Therapeutic Apheresis Market by Procedure in the US for the Years 2008 & 2012; Table 9: Therapeutic Apheresis Market by End Use in the US: 2007-2015 (Sales in US$ Thousand); Table 10: Percentage Breakdown of Therapeutic Apheresis Market by End Use in the US for the Years 2008 & 2012
COMPANIES PROFILED

Abstract

Although therapeutic apheresis is a potential market, soaring treatment costs and lack of awareness debilitate its growth. However, with increasing alliances and agreements, research for new procedures and more sophisticated applications underway, apheresis technology is likely to have major market opportunities for supplies, services and equipment. Reimbursement policies of both government and private insurance companies play a major role in the increase of therapeutic application in several diseases. Emerging applications of therapeutic apheresis in Autoimmune Diseases, Refractory Chronic GvHD, Lupus Erythematosus, Hyperlipidemia, Atherosclerosis and Renal Diseases are forecast to bolster volumes of growth. The pediatric segment provides a potential opportunity to expand the therapeutic apheresis market.

These and other market data and trends are presented in "Therapeutic Apheresis: US Market Review" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

2/14/2012 - 32

Therapeutic Apheresis - A US Market Review

Table of Contents

Abstract